Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
Avricore Health Inc. (AVCRF)
Standardized SEC financial data for Avricore Health Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001355736 · OTC · Pharmaceutical Preparations.
Revenue growth (YoY)
-48.8%
Return on equity
-59.7%
Ratios for fiscal year 2018, standardized from SEC filings.
Income statement
C$
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Cost of revenue
C$19K
C$16K
C$92K
C$1.3M
C$2.3M
C$2.9M
Gross profit
C$14K
C$17K
C$31K
C$457K
C$1.2M
C$1.9M
SG&A expense
C$247K
C$114K
C$183K
C$250K
C$339K
C$409K
Interest expense
—
C$79K
C$21K
—
—
—
Net income
-C$1.9M
-C$1.2M
—
—
—
—
Standardized from Avricore Health Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.